查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379138

2023-2028 年血液製备市场报告（按产品、抗血栓和抗凝血剂类型、抗血栓和抗凝血剂应用和地区）

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球血液製剂市场规模达到423亿美元。展望未来， IMARC Group预计到2028年市场规模将达到5,61亿美元，2022-2028年复合年增长率（CAGR）为4.9%。

捐血是一种挽救生命的程序，其中从捐血者身上抽取一个单位的血液。这种血液由细胞元素、胶体和晶体的混合物组成，需要将其分离才能用于患者。因此，血液製备方法被广泛采用，利用冷冻离心设备将一个单位的全血分离成不同的成分。这些成分通常包括冷沉淀、浓缩血小板、新鲜冷冻血浆和浓缩红血球 (PRBC) 浓缩物。此血液製备方法也最大化了每种血液成分对于不同应用的效用。

血液製备市场趋势：

由于冠状病毒病（COVID-19）病例激增且缺乏有效的治疗方法，多家医院正在依靠恢復期血浆作为危重患者的一种有希望的治疗方法。这是积极影响从健康捐血中分离血浆的血液製备方法需求的关键因素之一。除此之外，贫血、镰状细胞病、血友病和癌症等慢性疾病的日益流行正在刺激对输血的需求。由于世界各地政府和非政府组织（NGO）的宣传活动，捐血者数量不断增加，这共同促进了市场的成长。与此一致的是，外科手术数量的大幅增加也促进了市场的成长。此外，一些医疗机构正致力于采用先进的数位技术来快速分离血液成分。他们还利用射频识别（RFID）技术来维护血液库存记录，预计这将在未来几年扩大血液製备方法的应用。

本报告回答的关键问题

  • 2022年全球血液製剂市场规模有多大？
  • 2023-2028年全球血液製剂市场的预期成长率是多少？
  • 推动全球血液製剂市场的关键因素是什么？
  • COVID-19 对全球血液製剂市场有何影响？
  • 基于该产品的全球血液製剂市场的细分情况如何？
  • 根据抗血栓和抗凝血剂类型，全球血液製剂市场的细分如何？
  • 基于抗血栓和抗凝血剂应用的全球血液製剂市场的细分情况如何？
  • 全球血液製剂市场的重点区域有哪些？
  • 全球血液製剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球血液製备市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 全血
    • 市场走向
    • 关键环节
      • 红血球
      • 粒细胞
      • 电浆
      • 血小板
    • 市场预测
  • 血液成分
    • 市场走向
    • 关键环节
      • 全血成分
      • 浓缩红血球
      • 白血球减少 红血球
      • 冷冻血浆
      • 浓缩血小板
      • 冷沉淀
    • 市场预测
  • 血液衍生物
    • 市场走向
    • 市场预测

第 7 章：按抗血栓和抗凝血剂类型分類的市场细分

  • 血小板聚集抑制剂
    • 市场走向
    • 关键环节
      • 糖蛋白抑制剂
      • COX抑制剂
      • ADP拮抗剂
      • 其他的
    • 市场预测
  • 纤溶药物
    • 市场走向
    • 关键环节
      • 组织纤溶酶原激活剂 (TPA)
      • 链激酶
      • 尿激酶
    • 市场预测
  • 抗凝血剂
    • 市场走向
    • 关键环节
      • 肝素
      • 维生素 K 拮抗剂
      • 直接凝血酶抑制剂
      • 直接 Xa 因子抑制剂
    • 市场预测

第 8 章：抗血栓和抗凝血剂应用的市场区隔

  • 血小板增多症
    • 市场走向
    • 市场预测
  • 肺栓塞
    • 市场走向
    • 市场预测
  • 肾功能不全
    • 市场走向
    • 市场预测
  • 心绞痛血管併发症
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
    • Sanofi SA
Product Code: SR112023A4552

Abstract

The global blood preparation market size reached US$ 42.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 56.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028.

Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.

Blood Preparation Market Trends:

Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.

Breakup by Product:

Whole Blood

Red Cells

Granulocytes

Plasma

Platelets

Blood Components

Whole Blood Components

Packed Red Cells

Leukocyte Reduced Red Blood Cells

Frozen Plasma

Platelet Concentrate

Cryoprecipitate

Blood Derivatives

Breakup by Antithrombotic and Anticoagulants Type:

Platelet Aggregation Inhibitors

Glycoprotein Inhibitors

COX Inhibitors

ADP Antagonists

Others

Fibrinolytics

Tissue Plasminogen Activator (TPA)

Streptokinase

Urokinase

Anticoagulants

Heparins

Vitamin K Antagonists

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Breakup by Antithrombotic and Anticoagulants Application:

Thrombocytosis

Pulmonary Embolism

Renal Impairment

Angina Blood Vessel Complications

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.

Key Questions Answered in This Report

  • 1. What was the size of the global blood preparation market in 2022?
  • 2. What is the expected growth rate of the global blood preparation market during 2023-2028?
  • 3. What are the key factors driving the global blood preparation market?
  • 4. What has been the impact of COVID-19 on the global blood preparation market?
  • 5. What is the breakup of the global blood preparation market based on the product?
  • 6. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8. What are the key regions in the global blood preparation market?
  • 9. Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2022
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2022
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2023-2028
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2023-2028
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players